Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technology

8 Aug 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Organ Donation and Transplantation
Share to Pluripotent Stem Cells Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31402115
DOI: 10.1016/j.bbrc.2019.07.109

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted gene therapy in human-induced pluripotent stem cells from a patient with primary hyperoxaluria type 1 using CRISPR/Cas9 technologyPMID 31402115Read ↗

CRISPR/Cas9–mediated metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1Semantic proximity Read ↗

Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation.Semantic proximity Read ↗

Title: Identification of a novel GRHPR mutation in primary hyperoxaluria type 2 and establishment of patient-derived iPSC line.Semantic proximity Read ↗

CRISPR‐Cas9‐Based Genome Editing of Human Induced Pluripotent Stem CellsSemantic proximity Read ↗

Molecular and cell biology of primary hyperoxaluria type 1.Semantic proximity Read ↗

Crispr-mediated Gene Targeting of Human Induced Pluripotent Stem Cells.Semantic proximity Read ↗

Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9Semantic proximity Read ↗

Gene symbol: AGXT. Disease: primary hyperoxaluria type I.Semantic proximity Read ↗

<i>In vitro</i> and <i>In vivo</i> Genetic Disease Modelling via NHEJ-precise deletions using CRISPR/Cas9Semantic proximity Read ↗

Generation of an induced pluripotent stem cell line (CIMAi001-A) from a compound heterozygous Primary Hyperoxaluria Type I (PH1) patient carrying p.G170R and p.R122* mutations in the AGXT gene.Semantic proximity Read ↗

Editing the genome of hiPSC with CRISPR/Cas9: disease models.Semantic proximity Read ↗

Human somatic cell gene targeting.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.